94 related articles for article (PubMed ID: 2518523)
21. [Results of surgical treatment of the "minimal" forms of breast cancer].
Semiglazov VF; Orlov AA
Vestn Khir Im I I Grek; 1983 Mar; 130(3):47-51. PubMed ID: 6857957
[TBL] [Abstract][Full Text] [Related]
22. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
23. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
24. [Patey's radical mastectomy in combined treatment of breast cancer].
Datsenko VS; Rozanov IB; Sukhoveev PN; Vinogradov LI
Khirurgiia (Mosk); 1989 Dec; (12):81-5. PubMed ID: 2625904
[TBL] [Abstract][Full Text] [Related]
25. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
26. Locoregional recurrence in breast carcinoma patients.
Yildirim E
Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692
[TBL] [Abstract][Full Text] [Related]
27. [Anatomo-surgical considerations on the indications and technic of Patey's radical mastectomy].
Nemeth A; Roseano M
Chir Ital; 1981 Aug; 33(4):823-36. PubMed ID: 7034981
[TBL] [Abstract][Full Text] [Related]
28. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
30. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
31. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
32. [Risk of locally-advanced recurrences of breast cancer following organ-saving surgery].
Gurbanov SS; Matsko DE; Kanaev SV; Semiglazov VF
Vopr Onkol; 2009; 55(1):33-7. PubMed ID: 19435196
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of subcutaneous mastectomy with radical mastectomy.
Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
[TBL] [Abstract][Full Text] [Related]
34. [Incidence of local recurrence after breast preserving surgery].
Garami Z; Szluha K; Kósa C; Fülöp B; Lukács G
Magy Seb; 2006 Jun; 59(3):179-83. PubMed ID: 16937793
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of node-negative breast cancer in patients treated in a community hospital.
Hahneman BM; Thompson SJ; Babcock WH; Salters S
J S C Med Assoc; 1989 Dec; 85(12):560-4. PubMed ID: 2615325
[No Abstract] [Full Text] [Related]
36. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
37. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
38. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
39. Breast conservation in patients with multiple ipsilateral synchronous cancers.
Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR
J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405
[TBL] [Abstract][Full Text] [Related]
40. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
